Skip to main navigation

Top

Skip to main content

About Us

About Us
Genetically Defined Diseases

Genetically Defined Diseases
Pipeline

Pipeline
Patients & Partners

Patients & Partners
Investors

Investors
Inside Agios

Inside Agios

Press Releases

Investors Overview
News & Events
Stock Information
Corporate Governance
Financials
IR Resources

Year

Jan 10, 2022

Agios Highlights 2022 Anticipated Milestones and Priorities to Drive Company’s Strategic Vision in Genetically Defined Diseases

Learn More

PDF Version

Latest Form 10-K View PDF
Q3 2021 Earnings Presentation View PDF
Latest Form 10-Q View PDF
Corporate Fact Sheet View PDF
Corporate Responsibility View PDF

Connect with us on LinkedIn or follow us on Twitter as we push forward into changing the landscape for people with genetically defined diseases.

Visit our LinkedIn

Visit our Twitter

Contact
About Us
Patients & Partners
Careers

Agios Inc. © 2022

All right reserved.

Cookies Preferences
Copyright Info
Compliance
Sitemap
Privacy Notice
Terms of Use